EQRx Inc. (EQRX) Fundamentals

EQRx Inc is a biotechnology company. Its pipeline programs include two pre-registrational oncology assets that have shown assuring Phase 3 data (aumolertinib and sugemalimab), and multiple other clinical-stage programs.
SHARE INFORMATION
Market Cap$ 1,704,632,472
Shares Outstanding488,433,373
Float354,482,427
Percent Float72.58%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -0.39
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions249
Institutional Holdings Date2022-10-31
Institutional Bought Previous 3 Months32,881,582
Institutional Holdings Percent88.4%
Institutional Sold Previous 3 Months3,828,630
Insider Holdings Date2022-10-31
Insider Bought Previous 3 Months808,080
Insider Holdings Percent6.4
Insider Sold Previous 3 Months-
Insider Shares Owned28,764,747
TRADING INFO
52 Week High$ 8.70
52 Week Low$ 2.63
52 Week High Change$ 0.00
21 Day Moving Average$ 4.4819
21 Day Extended Moving Average$ 4.157
50 Day Moving Average$ 4.7077
50 Day Extended Moving Average$ 4.5719
200 Day Moving Average$ 4.5423
200 Day Extended Moving Average$ 4.8935
10 Day Average Volume3,580,054
20 Day Average Volume2,571,292
30 Day Average Volume2,400,735
50 Day Average Volume3,026,535
Alpha0.021201
Beta1.2544
Standard Deviation0.234039
R20.132775
7 Day Price Change$ 0.05
7 Day Percent Change1.45%
21 Day Price Change$ -1.82
21 Day Percent Change-34.28%
30 Day Price Change$ -1.32
30 Day Percent Change-27.44%
Month to Date Price Change$ -1.65
Month to Date Percent Change-32.1%
Quarter to Date Price Change$ -1.46
Quarter to Date Percent Change-29.49%
180 Day Price Change$ -0.81
180 Day Percent Change-18.84%
200 Day Price Change$ -0.23
200 Day Percent Change-6.18%
Year to Date Price Change$ -3.33
Year to Date Percent Change-48.83%

EQRx Inc. (EQRX) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book1.20
Total Debt To Equity0.00
Int Coverage0.00
Current Ratio24.30
Leverage Ratio1.10
Quick Ratio23.90
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio-8.30
Enterprise Value$ 180,534,469
Price to Sales0.00
Price to Free Cash-6.40
PE High Last 5 Years0.00
Price To Book1.20
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book1.20
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-14.37
Return on Equity-27.89
Return on Capital-30.07

EQRx Inc. (EQRX) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorErnst & Young LLP
CEOMelanie I. Nallicheri
Emplyoees244
Last AuditUQ
CIK0001843762
IndustryBiotechnology
SectorHealthcare
NAICSResearch and Development in the Physical(541715)
CONTACT INFO
Address50 Hampshire Street
Cambridge, MA 2139
Websitehttps://www.eqrx.com
Facsimile-
Telephone+1 617 315-2255
Email-


Your Recent History
NASDAQ
EQRX
EQRx
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.